Alejandro De La Hoz
Overview
Explore the profile of Alejandro De La Hoz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De La Hoz A, Pooja A, Kancharla A, Schechter-Perkins E, Ruiz-Mercado G, Baldwin M, et al.
Open Forum Infect Dis
. 2024 Dec;
11(12):ofae704.
PMID: 39703790
Background: Hepatitis C virus (HCV) guidelines recommend direct-acting antiviral (DAA) rescue regimens in cases of treatment failure, and first-line regimens for reinfection. In patients with barriers to follow-up after treatment,...
2.
De La Hoz A, Melo L, Canada F, Cubero J
Heliyon
. 2024 Nov;
10(21):e40032.
PMID: 39583814
Educational Robotics has had an important impact in recent years as it offers a number of advantages for students. The inclusion of robotics in any educational stage requires teachers with...
3.
De La Hoz A, Gadi N, Lopez C, Barrera-Godinez A, Miller N, Bourque D, et al.
Open Forum Infect Dis
. 2024 Oct;
11(10):ofae587.
PMID: 39474451
Migration routes determine exposure to endemic infections. We present a case of complex cutaneous leishmaniasis in a man with HIV infection who migrated to the United States from Haiti, where...
4.
De La Hoz A, Graves K, Bernstein J, Assoumou S
AIDS Care
. 2024 Jul;
36(12):1771-1780.
PMID: 38991115
HIV and hepatitis C virus (HCV) infection rates among persons, who use drugs, have risen during the US overdose crisis. We elicited patient perspectives about these interconnected infections to identify...
5.
Vergara-Samur H, Martinez-Vernaza S, De La Hoz A, Barahona-Correa J, Ortiz J, Gualtero-Trujillo S, et al.
Infez Med
. 2023 Sep;
31(3):374-383.
PMID: 37701377
Background: Direct-acting antivirals (DAA) were introduced to Latin America with the aim of eliminating hepatitis C (HCV) in the region. There are scarce data on the outcomes of people living...
6.
De La Hoz A, Melo L, Alvarez A, Canada F, Cubero J
Healthcare (Basel)
. 2023 Aug;
11(15).
PMID: 37570400
In recent years, there has been a lack of healthy lifestyle habits in the population, including hydration, with negative consequences for health. At the same time, advances in technology have...
7.
Tabarani C, De La Hoz A, Wanger A, Flores A, Arias C
Pediatr Infect Dis J
. 2023 May;
42(8):667-671.
PMID: 37171940
Background: Salmonellosis continues to be a major public health issue and high rates of infection are reported among young children. The contemporary clinical epidemiology of pediatric Salmonella spp. infections in...
8.
Valderrama-Beltran S, Martinez-Vernaza S, Figueredo M, Martinez E, Blair K, Cuervo-Rojas J, et al.
Int J STD AIDS
. 2022 May;
33(7):641-651.
PMID: 35502981
Introduction: HIV is an independent risk factor for cardiovascular diseases (CVD). There is insufficient information regarding comorbidities and cardiovascular risk factors in the Colombian HIV population. The aim of this...
9.
Nigo M, Rasmy L, May S, Rao A, Karimaghaei S, Kannadath B, et al.
Int J Infect Dis
. 2021 Oct;
113:148-154.
PMID: 34597766
Background: Studies have shown conflicting results on the efficacy of tocilizumab (TCZ) for patients with COVID-19, with many confounders of clinical status and limited duration of the observation. Here, we...
10.
De La Hoz A, Cubero J, Melo L, Duran-Vinagre M, Sanchez S
Int J Environ Res Public Health
. 2021 Jul;
18(12).
PMID: 34205773
As we have seen as a consequence of the COVID-19 global pandemic, our scientific-technological society requires a transformation of knowledge in a global, digital and virtual manner. In light of...